{"id":"W4200103238","doi":"10.1200/jco.21.01546","title":"Measurable Residual Disease Response and Prognosis in Treatment-Naïve Acute Myeloid Leukemia With Venetoclax and Azacitidine","year":2021,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":170,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute; Genentech; Pfizer; AstraZeneca; Eli Lilly and Company","keywords":"Venetoclax; Medicine; Azacitidine; Internal medicine; Minimal residual disease; Myeloid leukemia; Oncology; Complete remission; Gastroenterology; Multivariate analysis; Leukemia; Chemotherapy; Chronic lymphocytic leukemia","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003544363,0.0002051679,0.001486209,0.0002262765,0.00005929179,0.0000275248,0.00009581057,0.0003105874,0.00006256968],"category_scores_gemma":[0.005830083,0.0001356669,0.0001552382,0.0003068743,0.0004687156,0.0001718048,0.00009438275,0.001060429,0.000004784263],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001698839,"about_ca_system_score_gemma":0.01841646,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00004315213,"about_ca_topic_score_gemma":0.0001335562,"domain_scores_codex":[0.9960346,0.001325941,0.001395655,0.0003750804,0.000478309,0.0003904655],"domain_scores_gemma":[0.9939666,0.003682139,0.0005462779,0.0002301273,0.0005504246,0.001024446],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.2172775,0.00131455,0.5892345,0.0001005581,0.001564058,0.08785281,0.0003678015,0.00003278726,0.004665335,0.00005451289,0.00290587,0.09462964],"study_design_scores_gemma":[0.02989148,0.02705143,0.912281,0.0003440158,0.0009907858,0.005646705,0.0003545431,0.0002541738,0.001553236,0.0001646824,0.02129029,0.000177628],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9756107,0.001940533,0.000008857353,0.02159223,0.00009603702,0.0003239959,0.00001285729,0.000008944107,0.000405882],"genre_scores_gemma":[0.9856933,0.006943158,0.004580177,0.0008410498,0.0004614972,0.00002115801,0.000006847828,0.00003183229,0.00142097],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3230465,"threshold_uncertainty_score":0.9871482,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1011598271163015,"score_gpt":0.4356241830475861,"score_spread":0.3344643559312846,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}